New Protein-Degradation Mechanism Offers Hope for Inherited Heart Arrhythmia Treatment

An international research team has discovered a protein-degradation mechanism responsible for catecholaminergic polymorphic ventricular tachycardia (CPVT), a rare inherited heart condition primarily affecting children and young adults. Led by researchers at Spain's Centro Nacional de Investigaciones Cardiovasculares Carlos III in collaboration with Italian institutions, this breakthrough identifies a new therapeutic target for treating this potentially life-threatening arrhythmia. CPVT causes dangerous irregular heartbeats triggered by physical activity or emotional stress, making it a significant cause of sudden cardiac death in young people. This discovery could lead to novel treatment approaches that address the underlying protein degradation mechanisms rather than just managing symptoms.